Drug development blossoms for rare, fatal bone disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38815021.
- Also identified by DOI 10.1126/science.adq7356.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Five drugs are now approved or in trials for genetic condition that triggers misplaced bone growth.
Medical subject headings
- Bone Diseases
- Drug Development
- Rare Diseases
- Myositis Ossificans